Y-mAbs Therapeutics to Present at Key Investor Conferences
Y-mAbs Therapeutics Engages Investors at Upcoming Conferences
Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a prominent player in the biopharmaceutical sector, is set to capture the attention of investors this September. The company specializes in groundbreaking radioimmunotherapy and antibody-based therapies aimed at revolutionizing cancer treatment. Michael Rossi, the dynamic CEO of Y-mAbs, will lead presentations at two highly anticipated investor conferences, showcasing the company's innovative approach to oncology.
Key Conferences Scheduled for September
The first event on the calendar is the Morgan Stanley 22nd Annual Global Healthcare Conference, taking place on September 6, 2024, at 1:50 p.m. ET. This format will allow for an engaging fireside chat, in which investors can gain insights directly from the leadership team. Following this, Y-mAbs will also participate in the Cantor Global Healthcare Conference on September 17, 2024, at 3:40 p.m. ET, again featuring a fireside chat designed for in-depth discussion and investor interaction.
Live Webcasts and Archived Sessions
For those unable to attend in person, Y-mAbs is committed to accessibility. Live webcasts of both presentations will be available on the company's investor relations website, with recordings kept accessible for at least 30 days. This initiative underscores Y-mAbs' dedication to keeping stakeholders informed about its advancements in cancer therapy.
About Y-mAbs and Its Innovative Therapies
Y-mAbs Therapeutics stands at the forefront of biopharmaceutical development, offering promising new therapies that harness the power of immunotherapy for cancer treatment. The company's cutting-edge technologies include its Self-Assembly DisAssembly (SADA) Pretargeted Radioimmunotherapy Platform (PRIT) and specialized bispecific antibodies crafted through the Y-BiClone technology. Notably, the advanced product pipeline features DANYELZA® (naxitamab-gqgk), recognized as the first FDA-approved treatment for patients facing relapsed or refractory high-risk neuroblastoma.
Commitment to Cancer Treatment
Y-mAbs' focus on research and development aims to provide vital solutions for patients who have limited treatment options. By participating in these conferences, the company not only generates investor interest but also raises awareness of its innovative therapies. The commitment to fighting cancer is not just a business strategy; it's a mission that impacts lives directly.
Investor Relationship Stronghold
Investor engagement is vital for a company looking to succeed in highly competitive sectors. The leadership of Y-mAbs understands this necessity and is eager to share the company's journey, vision, and the developments in their robust pipeline. The CEO's direct presentations enable potential and current investors to ask pertinent questions and grasp the strategic direction of Y-mAbs.
Contact Information for Investors
For additional inquiries, investors can reach out to Courtney Dugan, VP and Head of Investor Relations, at cdu@ymabs.com.
Frequently Asked Questions
What is Y-mAbs Therapeutics known for?
Y-mAbs Therapeutics specializes in developing radioimmunotherapy and antibody-based therapies aimed at treating cancer, particularly neuroblastoma.
When will Y-mAbs present at investor conferences?
Y-mAbs will present at the Morgan Stanley Conference on September 6, 2024, and at the Cantor Conference on September 17, 2024.
How can investors access the conference presentations?
Investors can access live webcasts of the presentations on Y-mAbs' investor relations website, with recordings available for 30 days afterward.
What notable therapy does Y-mAbs offer?
Y-mAbs offers DANYELZA® (naxitamab-gqgk), the first FDA-approved treatment for high-risk neuroblastoma patients who have had insufficient responses to prior therapies.
How can investors contact Y-mAbs for more information?
Investors can contact Courtney Dugan at cdu@ymabs.com for inquiries about the company and its investor relations.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Equature's 2024.3 Software Revolutionizes Public Safety Operations
- Jamie Foxx Brings Humor to BetMGM's 2024 Football Campaign
- Wipfli Unveils 2024 Annual Report Detailing Growth and Innovation
- Autonomous Cars Forecast: Growth to USD 43.44 Billion By 2032
- Investing Insights: Nvidia Versus Arm Holdings in AI Sector
- Agmatix Unveils RegenIQ: Revolutionizing Regenerative Agriculture
- BoomerangFX Expands Innovative Solutions in Asia and Latin America
- Costco to Expand with Four New Locations by End of 2024
- Bloomberg CityLab 2024: Global Mayors Gather in Mexico City
- BCFNJC's What We Heard Report from First Nations Justice Forum
- Asia Pacific Wireless Earphones Market Expected to Thrive
- Cork Packaging Market Expected to Hit USD 2.7 Billion Growth
- MICE Industry Expected to Reach $1,337 Billion by 2033
- Packaging Automation Market Growth Driven by E-commerce Boom
- Status of Audit for Aktsiaselts Silvano Fashion Group Revealed
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
- Portable Projector Market Growth Projections: $2.1 Billion by 2029
- Celebrate the Festive Season at The Ocean Club, Bahamas
- Ethical AI Transformation: The P&C Insurance Industry's Role
- HomeSafe Alliance Achieves Milestone Of 100 Military Moves
- Xiaohongshu's Street Life Festival Draws Record Attendance and Engagement
- Starlight Children's Foundation Celebrates Childhood Cancer Month
- Sandals Resorts Partners with Leo Burnett for Creative Vision
- Drew Ysseldyke Elevated to President & CEO of Grand River Bank
- Innovative Wireless Charging Technology Utilizing RF Signals
Recent Articles
- Supermicro Addresses Concerns Over Annual Report Filing
- HAAS Alert Enhances Safety Cloud with MDS Compatibility
- Middlefield Canadian Income PCC's Current Net Asset Value Insights
- Corporate Profit Challenges: Earnings Outlook for 2025
- Assisted Living Locators' Inspiring Initiative for Alzheimer's Month
- Light The Night: Illuminate Hope for Blood Cancer Patients
- Music Licensing, Inc. Expands Portfolio with New Acquisition
- RecycLiCo Battery Materials Appoints Dr. Maryam Rasouli as Principal Engineer
- Procaps Group Outlines Strategic Vision for Future Success
- CenExel Launches Advanced PET Scan Unit for Research
- IR Spectroscopy Market Growth Predictions Highlighted by R&D
- 180 Degree Capital Corp. Reports Discount Management Highlights
- Nord Anglia Education Celebrates Student I/GCSE Success
- Henry Steinberg Takes Over as Global Head of EQT Exeter
- National Police Association Opposes New Liability Insurance Bill
- Cassava Sciences to Shine at H.C. Wainwright Conference
- VCI Global Secures $18 Million Contract for IPO Listings
- Hearing Aids Market Projected to Reach $20.68 Billion by 2033
- Piston Air Motors Market Projects Growth to $987 Million by 2034
- Bio-Path Holdings Set to Present at the Global Investment Conference
- Medical Properties Trust Navigates Challenges with New Deal
- Intel Faces Dow Removal Threat Amid Share Price Slump
- Color Star Welcomes Ren Pelosi as New Vice President
- Join the Class Action Against Lululemon Athletica Inc. Today
- Orthofix Medical Inc. Faces Class Action: Important Investor Update